Physician profile
David Buchin
NPI 1417052242
$73,972.19
in general payments reported to CMS, 2019-2025
16 companies · $5,441 in 2025
The $5,441 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $11K · 2021: $9,073 · 2022: $3,936 · 2023: $1,388 · 2024: $12K · 2025: $5,441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,500 · Food and Beverage: $4,931 · Education: $4,000 · Travel and Lodging: $570 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,500.00 |
| Food and Beverage | $4,931.32 |
| Education | $4,000.00 |
| Travel and Lodging | $570.20 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $42,339.39 | 2019-2025 | Wegovy |
| Intuitive Surgical, INC. | $27,358.24 | 2019-2025 | Da Vinci Surgical System |
| Dilon Technologies, INC. | $1,309.00 | 2023-2025 | Hemoblast Bellows |
| Intra-Sana Laboratories | $725.78 | 2022-2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Ethicon US, LLC | $678.37 | 2021-2023 | Linx Reflux Management System |
| Medtronic, INC. | $673.23 | 2022-2024 | Ligasure, Signia, Rapidvac |
| Smith+Nephew, INC. | $336.09 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $132.85 | 2024-2025 | Voquezna |
| Covidien Lp | $113.63 | 2019 | |
| Integra Lifesciences Corporation | $87.92 | 2020-2021 | |
| Tei Biosciences INC | $87.87 | 2019 | |
| Stryker Corporation | $46.13 | 2023 | Spy-Phi System |
| Currax Pharmaceuticals LLC | $31.71 | 2020-2025 | Contrave |
| Takeda Pharmaceuticals U.S.A., INC. | $18.50 | 2023 | Gattex |
| Conmed Corporation | $17.87 | 2025 | Airseal |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $15.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Buchin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.